Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
Ratnayake G, Reinwald S, Shackleton M, Moore M, Voskoboynik M, Ruben J, van Zelm MC, Yu D, Ward R, Smith R, Haydon A, Senthi S. Ratnayake G, et al. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):150-156. doi: 10.1016/j.ijrobp.2020.05.022. Epub 2020 May 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32450331 Clinical Trial.
Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma.
Mason R, Dearden HC, Nguyen B, Soon JA, Smith JL, Randhawa M, Mant A, Warburton L, Lo S, Meniawy T, Guminski A, Parente P, Ali S, Haydon A, Long GV, Carlino MS, Millward M, Atkinson VG, Menzies AM. Mason R, et al. Among authors: haydon a. Pigment Cell Melanoma Res. 2020 Mar;33(2):358-365. doi: 10.1111/pcmr.12831. Epub 2019 Nov 2. Pigment Cell Melanoma Res. 2020. PMID: 31587511
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial.
Eggermont AMM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, Krepler C, Ibrahim N, Marreaud S, van Akkooi A, Robert C, Suciu S. Eggermont AMM, et al. Among authors: haydon a. JAMA Oncol. 2020 Apr 1;6(4):519-527. doi: 10.1001/jamaoncol.2019.5570. JAMA Oncol. 2020. PMID: 31895407 Free PMC article. Clinical Trial.
Body size and composition and colon cancer risk in men.
MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. MacInnis RJ, et al. Among authors: haydon am. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):553-9. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066919
Body size and composition and colon cancer risk in women.
MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, Giles GG. MacInnis RJ, et al. Among authors: haydon am. Int J Cancer. 2006 Mar 15;118(6):1496-500. doi: 10.1002/ijc.21508. Int J Cancer. 2006. PMID: 16187280
Body size and composition and risk of rectal cancer (Australia).
MacInnis RJ, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. MacInnis RJ, et al. Among authors: haydon am. Cancer Causes Control. 2006 Dec;17(10):1291-7. doi: 10.1007/s10552-006-0074-y. Cancer Causes Control. 2006. PMID: 17111261
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.
English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG. English DR, et al. Among authors: haydon am. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1774-80. doi: 10.1158/1055-9965.EPI-08-0091. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18628431
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page